copyright Pen has emerged as a groundbreaking therapy for type 2 diabetes. This innovative injectable medication utilizes the power of a glucagon-like peptide-1 receptor agonist to effectively lower blood sugar levels. Clinical research have demonstrated copyright Pen's success rate in improving glycemic control, leading to a significant reduction